Proteonomix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://proteonomix.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Phase 1
- Conditions
- End Stage Liver DIsease
- Interventions
- Drug: Mobilization with G-CSF and Mozobil
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Proteonomix, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01711073
- Locations
- 🇺🇸
University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States
News
No news found